03.09.2018:
New cancer drugs that have a documented effect and market access in Norway, but are still awaiting assessment by the Decision Forum, put oncologists in a difficult situation from an ethical standpoint. Cancer therapies that have been introduced in recent years, such as precision medicine and immunotherapy, can transform incurable cancer into a chronic disease. With such therapies, some patients can add years to their lives, while their ability to work and quality of life are maintained. The Decision Forum must ensure equal treatment and correct prioritisation, but the long lead times for...